dRx Capital Novartis Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 42

  • Portfolio
  • 24

  • Exits
  • 2

Exits

dRx Capital Novartis General Information

Description

Founded in 2015, dRx Capital Novartis is Novartis' digital health venture capital firm based in Basel, Switzerland. The firm invests in entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on artificial intelligence & machine learning, big data, research and development optimization, patient care, and pharma supply chain and commercialization.

Contact Information

Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Corporate Venture Capital
Primary Office
  • Novartis Campus
  • 4056 Basel
  • Switzerland

dRx Capital Novartis Investments (42)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Octave 26-Jul-2023 Later Stage VC 0000 Decision/Risk Analysis Generating Revenue 0000 000000 00.0
RxLightning 06-Jun-2023 00000 00000 000.00 Enterprise Systems (Healthcare) Generating Revenue 0000 000000 00.0
Holmusk 06-Jan-2023 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 0000 000000 00.0
H1 (Healthcare Technology Systems) 09-Jun-2022 00000 00000 00000 Other Healthcare Technology Systems Generating Revenue 0000 000000 00.0
Peptone 09-Jun-2022 00000 00000 0000 Biotechnology Generating Revenue
Koneksa 07-Feb-2022 00000 00000 0000 Discovery Tools (Healthcare) Generating Revenue 0000 000000 00.0
NuvoAir 19-Jan-2022 00000 00000 0000 Clinics/Outpatient Services Generating Revenue 0000 000000 00.0
Pear Therapeutics 03-Dec-2021 0000 00000 Other Healthcare Technology Systems Bankruptcy: Admin/Reorg
Cala Health 16-Nov-2021 Later Stage VC 0000 Therapeutic Devices Generating Revenue
Flywheel (Database Software) 10-Nov-2021 Later Stage VC 000.00 Database Software Generating Revenue
You’re viewing 10 of 42 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

dRx Capital Novartis Exits (2)

Company Name Exit Date Exit Type Exit Size
Pear Therapeutics 03-Dec-2021 Reverse Merger 00000
Science 37 06-Oct-2021 0000000 000000 00000
To view dRx Capital Novartis’s complete exits history, request access »

dRx Capital Novartis Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

dRx Capital Novartis Team (8)

Name Title Deals Funds Boards Office
Rana Lonnen Ph.D Managing Director 00 0 Basel, Switzerland
You’re viewing 1 of 8 team members. Get the full list »

dRx Capital Novartis Co-Investors (151)

Name With Exits Lead Partner Series Industry
McKesson Ventures 6 0 Series chart Industry bar
Novartis Pharma 0 0 Series chart Industry bar
Novartis 0 0 Series chart Industry bar
S32 0 0 Series chart Industry bar
Lux Capital 0 0 0 Series chart Industry bar
You’re viewing 5 of 151 co-investors. Get the full list »